O-Xylene → 3-[4-[4-(2-Quinolyl)-1-piperazinyl]butyl]-3-azabicyclo[3.2.1]octane-2,4-dione

HRID 1253262노트

반응식

HRID 1253262 반응식
[CH:1]1([C:9]([OH:11])=O)[CH2:5][CH2:4][CH:3]([C:6]([OH:8])=O)[CH2:2]1.[NH2:12][CH2:13][CH2:14][CH2:15][CH2:16][N:17]1[CH2:22][CH2:21][N:20]([C:23]2[CH:32]=[CH:31][C:30]3[C:25](=[CH:26][CH:27]=[CH:28][CH:29]=3)[N:24]=2)[CH2:19][CH2:18]1.C1(C)C(C)=CC=CC=1>O>[N:24]1[C:25]2[C:30](=[CH:29][CH:28]=[CH:27][CH:26]=2)[CH:31]=[CH:32][C:23]=1[N:20]1[CH2:19][CH2:18][N:17]([CH2:16][CH2:15][CH2:14][CH2:13][N:12]2[C:6](=[O:8])[CH:3]3[CH2:2][CH:1]([CH2:5][CH2:4]3)[C:9]2=[O:11])[CH2:22][CH2:21]1

참가 물질

5

반응물 3

HCID 7237O-XyleneHCID 1072161,3-Cyclopentanedicarboxylic acidHCID 212437031-(4-Aminobutyl)-4-(2-quinolyl)piperazine

생성물 1

HCID 141563653-[4-[4-(2-Quinolyl)-1-piperazinyl]butyl]-3-azabicyclo[3.2.1]octane-2,4-dione

시약·촉매·용매 1

HCID 962Water용매

실험 절차

1,3-Cyclopentane dicarboxylic acid (1.6 g., 10 mmole) and 1-(4-aminobutyl)-4-(2-quinolyl)piperazine (2.8 g., 10 mmole) were combined in 200 ml. of xylene and refluxed for 24 hours with water removal via a Dean-Stark trap. The solvent was then removed in vacuum and the residue redissolved in chloroform and filtered through 75 g. of silica gel. The column was rinsed with 5% ethanol/chloroform and the product-containing fractions were combined and evaporated. The residue was recrystallized from isopropanol with the addition of 4N isopropanolic HCl to give 820 mg. of the title compound as the dihydrochloride hemihydrate; m.p. 240°-242° C.

후처리

  1. customThe solvent was then removed in vacuum
  2. dissolutionthe residue redissolved in chloroform
  3. filtrationfiltered through 75 g
  4. washThe column was rinsed with 5% ethanol/chloroform
  5. customevaporated
  6. customThe residue was recrystallized from isopropanol with the addition of 4N isopropanolic HCl
  7. customto give 820 mg

출처 및 근거

ORD 기록
ord-b085f95e938f4d4f9b60dc63473ae7dd
출처 데이터셋
uspto-grants-1988_05
특허 번호
US04748240

반응 노트

불러오는 중…